XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $559 | +7.1% | 14,515 | -0.6% | 0.02% | 0.0% |
| Q1 2023 | $522 | -9.7% | 14,598 | -0.3% | 0.02% | -12.0% |
| Q4 2022 | $578 | -99.9% | 14,649 | -15.8% | 0.02% | +4.2% |
| Q3 2022 | $628,000 | -6.3% | 17,400 | -21.0% | 0.02% | +20.0% |
| Q2 2022 | $670,000 | -0.4% | 22,025 | -0.0% | 0.02% | +25.0% |
| Q1 2022 | $673,000 | -14.9% | 22,031 | -13.0% | 0.02% | 0.0% |
| Q4 2021 | $791,000 | +105.5% | 25,329 | +0.7% | 0.02% | +77.8% |
| Q3 2021 | $385,000 | -21.3% | 25,165 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $489,000 | +10.1% | 26,245 | +5.8% | 0.01% | 0.0% |
| Q1 2021 | $444,000 | – | 24,805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |